Short answer
Clorox (CLX) filed its Q3 2026 10-Q quarterly report on Nov 2, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $1.9B (up 33.3% year over year) with net income of $170M.
Q3 2026 key financials · XBRL
- Revenue
- $1.9B
- +33.3% YoY
- Net income
- $170M
- +112.5% YoY
- Gross margin
- 40.4%
- EPS (diluted)
- $1.39
- +113.8% YoY
Source: XBRL data from the Clorox (CLX) Q3 2026 10-Q on SEC EDGAR. USD.
Clorox Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1,905M, up 33% YoY from $1,429M, driven by GOJO acquisition and lapping ERP-related shipment impacts
- Gross margin 40.4% vs 41.7% YoY, down 130 basis points from higher commodity, manufacturing and logistics costs
- Best segment: Health and Wellness sales up 55%, adjusted EBIT up 69%; worst: International sales up 11%, adjusted EBIT up 63%
- Operating cash flow $143M vs $93M YoY; financing outflows $68M, with $1,175M debt primarily funding GOJO acquisition
- Outlook: volatile, challenging environment; tariff, consumer spending, commodity and geopolitical headwinds, with continued brand investment and GOJO integration Candida
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Clorox quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.